Lexeo Therapeutics, Inc. (LXEO)
6.29
+0.02
(+0.32%)
USD |
NASDAQ |
Feb 20, 16:00
6.25
-0.04
(-0.64%)
After-Hours: 20:00
Lexeo Therapeutics Total Assets (Quarterly) : 143.84M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Johnson & Johnson | 199.21B |
| Insmed, Inc. | 2.265B |
| Eli Lilly & Co. | 112.48B |
| Madrigal Pharmaceuticals, Inc. | 1.260B |
| Phathom Pharmaceuticals, Inc. | 240.29M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 23.01M |
| Shareholders Equity (Quarterly) | 120.83M |
| Debt to Equity Ratio | 0.07 |
| Current Ratio | 7.399 |
| Net Debt Paydown Yield | 0.22% |